{
  "regulations" : [ ],
  "hardInstances" : [ ],
  "withoutRegulations" : [ {
    "sentence_tokens" : [ "All", "patients", "(", "male", "and", "female", ",", "age", ":", "18", "years", "and", "older", ",", "ECOG", "performance", "status", "0", "-", "1", ")", "with", "clinically", "suspected", "lung", "cancer", "that", "are", "scheduled", "for", "surgical", "cancer", "therapy", "at", "the", "Thoraxklinik", "Heidelberg", "will", "be", "screened", "for", "eligibility", "to", "participate", "in", "the", "NEOMUN-trial", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 14, 15, 16, 17, 18, 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "In", "the", "light", "of", "the", "efficacy", "results", "it", "is", "clear", ",", "that", "new", "multimodal", "treatment", "strategies", "are", "direly", "needed", "in", "order", "to", "improve", "long", "term", "survival", "following", "curative", "intent", "surgery.Recently", ",", "immunotherapies", "targeting", "the", "PD-1", "and", "PD-L1", "pathway", "have", "had", "significant", "impact", "on", "survival", "in", "patients", "with", "advanced", "stages", "of", "NSCLC", "in", "comparison", "to", "standard", "chemotherapy", "[", "10", "]", "." ],
    "entities_indices" : [ [ 34, 35 ], [ 36, 37 ], [ 50, 51 ] ]
  }, {
    "sentence_tokens" : [ "Neoadjuvant", "anti-programmed", "Death-1", "immunotherapy", "by", "Pembrolizumab", "in", "resectable", "nodal", "positive", "stage", "II/IIIa", "non-small-cell", "lung", "cancer", "(", "NSCLC", ")", ":", "the", "NEOMUN", "trial", "." ],
    "entities_indices" : [ [ 1, 2, 3 ], [ 5, 6 ] ]
  }, {
    "sentence_tokens" : [ "NCT02938624", ";", "NCT03217071", ";", "NCT02818920", ";", "NCT02259621", ")", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 2, 3 ], [ 4, 5 ], [ 6, 7 ] ]
  }, {
    "sentence_tokens" : [ "Detailed", "research", "will", "be", "conducted", "to", "further", "investigate", "the", "tumor", "microenvironment", ",", "tumor", "mutational", "burden", ",", "mutational", "status", ",", "cytokine", "expression", "levels", "and", "genomic", "alterations", "." ],
    "entities_indices" : [ [ 9, 10, 11 ], [ 12, 13 ] ]
  }, {
    "sentence_tokens" : [ "Primary", "objectives", "are", "to", "assess", "the", "feasibility", "and", "safety", "of", "a", "neoadjuvant", "immunotherapy", "and", "to", "assess", "antitumor", "activity", "of", "Pembrolizumab", "with", "regard", "to", "clinical", "and", "pathological", "tumor", "response", "." ],
    "entities_indices" : [ [ 19, 20 ], [ 26, 27 ] ]
  }, {
    "sentence_tokens" : [ "Further", "results", "are", "eagerly", "awaited", "to", "define", "more", "subgroups", "that", "are", "suitable", "for", "anti-PD-1", "therapy.Irrespective", "of", "the", "results", "in", "metastatic", "stage", "IV", "patients", ",", "the", "predictive", "value", "of", "the", "PD-L1", "status", "might", "have", "a", "different", "impact", "in", "patients", "with", "non", "metastatic", "earlier-stage", "lung", "cancer", "with", "less", "tumor", "burden", "." ],
    "entities_indices" : [ [ 29, 30 ], [ 46, 47 ] ]
  }, {
    "sentence_tokens" : [ "The", "translational", "study", "research", "program", "will", "raise", "the", "opportunity", "to", "generate", "further", "data", "to", "elucidate", "the", "role", "of", "different", "PD-L1", "expression", "levels", "in", "the", "context", "of", "neoadjuvant", "immunotherapy.In", "addition", "to", "the", "PD-L1", "status", "analysis", ",", "EGFR", "mutation", "and", "ALK", "translocation", "have", "been", "implemented", "in", "routine", "diagnostics", "and", "represent", "important", "prognostic", "parameters", "in", "the", "era", "of", "targeted", "therapy", "[", "29", "]", "." ],
    "entities_indices" : [ [ 19, 20 ], [ 31, 32 ], [ 35, 36 ], [ 38, 39 ], [ 53, 54 ] ]
  }, {
    "sentence_tokens" : [ "The", "scope", "of", "the", "enrolled", "NEOMUN", "trial", "is", "to", "generate", "pilot", "data", "on", "the", "efficacy", ",", "safety", "and", "the", "feasibility", "of", "a", "neoadjuvant", "anti-PD-1", "immunotherapy", "with", "Pembrolizumab", "." ],
    "entities_indices" : [ [ 10, 11 ], [ 26, 27 ] ]
  }, {
    "sentence_tokens" : [ "The", "feasibility", "and", "safety", "of", "neoadjuvant", "immunotherapy", "prior", "to", "tumor", "resection", "has", "been", "proven", "in", "a", "recently", "published", "study", "by", "Forde", "et", "al.", "Preliminary", "data", "shows", "encouraging", "results", "in", "clinical", "and", "pathological", "response", "evaluation", "[", "12", "]", "." ],
    "entities_indices" : [ [ 9, 10 ] ]
  }, {
    "sentence_tokens" : [ "Patients", "with", "locally", "advanced", "(", "T2-T4", ")", "tumors", "or", "limited", "nodal", "disease", "(", "N1", ",", "unilevel", "N2", ")", "do", "profit", "from", "a", "multimodal", "therapy", "including", "surgery", "followed", "by", "adjuvant", "cisplatin", "duplet", "chemotherapy", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 29, 30 ] ]
  }, {
    "sentence_tokens" : [ "functional", "(", "PET", "activity", "(", "standardized", "uptake", "value", "[", "SUV", "]", "[", "15", "]", ")", "andpathological", "response", "parameters", "(", "regression", "grading", "according", "to", "Junker", "criteria", "[", "16", "]", ")", "*", "Immunotherapy-trials", "described", "unique", "patterns", "of", "tumor", "response", "(", "pseudoprogression", ")", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 35, 36 ] ]
  }, {
    "sentence_tokens" : [ "According", "to", "current", "guidelines", "surgical", "tumor", "resection", "is", "the", "primary", "treatment", "in", "this", "patient", "cohort", "." ],
    "entities_indices" : [ [ 5, 6 ] ]
  }, {
    "sentence_tokens" : [ "Lung", "cancer", "is", "one", "of", "the", "leading", "causes", "of", "death", "worldwide", "with", "approximately", "230.000", "new", "diagnoses", "per", "year", "in", "the", "United", "States", "and", "410.000", "in", "Europe", "[", "1", ",", "2", "]", "." ],
    "entities_indices" : [ [ 9, 10 ] ]
  }, {
    "sentence_tokens" : [ "In", "contrast", "to", "standard", "cisplatin", "based", "chemotherapy", ",", "novel", "drugs", "modulating", "the", "patient", "'", "s", "immune-system", "unleashing", "the", "anti-tumor", "immunity", "have", "been", "implemented", "into", "modern", "treatment", "strategies", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Taking", "this", "into", "account", ",", "it", "is", "uncontroversial", "that", "a", "profound", "interaction", "between", "the", "tumor", "and", "its", "autologous", "immune-system", "is", "necessary", "to", "induce", "tumorspecific", "t-cells", "to", "overcome", "tumor", "induced", "tolerance", "and", "to", "generate", "and", "activate", "T-cell", "memory", "." ],
    "entities_indices" : [ [ 14, 15 ], [ 27, 28 ] ]
  }, {
    "sentence_tokens" : [ "Further", "examinations", "of", "tumor", "tissue", "taken", "pre-", "and", "post", "Pembrolizumab", "will", "include", "whole", "genome", "sequencing", "and", "FACS", "examination", "of", "the", "intratumoral", "immune", "infiltrate", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 9, 10 ] ]
  }, {
    "sentence_tokens" : [ "Distant", "metastatic", "disease", "will", "be", "radiologically", "ruled", "out", "using", "a", "diagnostic", "positron-emission-tomography-scan", "(", "PET", ")", "of", "the", "whole", "body", "and", "magnetic", "resonance", "imaging", "of", "the", "brain", "(", "MRI", ")", "." ],
    "entities_indices" : [ [ 13, 14 ], [ 27, 28 ] ]
  }, {
    "sentence_tokens" : [ "Several", "factors", "contributing", "to", "a", "false", "negative", "or", "a", "false-low", "PD-L1", "status", "have", "recently", "been", "identified", "[", "28", "]", "." ],
    "entities_indices" : [ [ 10, 11 ] ]
  }, {
    "sentence_tokens" : [ "A", "p-value", "of", "<", "0.05", "will", "be", "considered", "statistically", "significant.For", "the", "analysis", "of", "adverse", "events", ",", "summary", "tables", "providing", "the", "number", "and", "percentage", "of", "patients", "will", "be", "generated", "for", "the", "incidence", "of", "AEs", "overall", "and", "by", "severity", "." ],
    "entities_indices" : [ [ 32, 33 ] ]
  }, {
    "sentence_tokens" : [ "Histological", "confirmation", "of", "NSCLC", "will", "be", "provided", "by", "either", "transbronchial", "biopsy", "(", "TBB", ")", ",", "transbronchial", "needle", "aspiration", "(", "TBNA", ")", "or", "transthoracic", "biopsy", "(", "ultrasound", "guided", "or", "computed", "tomography", "guided", ")", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 12, 13 ] ]
  }, {
    "sentence_tokens" : [ "The", "study", "is", "designed", "as", "an", "open-label", ",", "single", "arm", ",", "prospective", ",", "monocenter", ",", "phase", "II", "study", "including", "30", "patients", "with", "NSCLC", "stage", "II/IIIA", "suitable", "for", "curative", "intent", "surgery", "." ],
    "entities_indices" : [ [ 9, 10 ] ]
  }, {
    "sentence_tokens" : [ "Based", "on", "these", "experiences", ",", "aim", "of", "the", "NEOMUN", "investigator", "initiated", "trial", "(", "NCT03197467", ";", "EudraCT", "No.", ":", "2017", "-", "000105-20", ")", "is", "to", "assess", "feasibility", "and", "safety", "of", "neoadjuvant", "anti", "PD-1", "immunotherapy", "followed", "by", "curative", "intent", "surgery", "." ],
    "entities_indices" : [ [ 15, 16, 17, 18, 19, 20, 21, 22 ], [ 31, 32 ] ]
  }, {
    "sentence_tokens" : [ "Based", "on", "this", ",", "the", "protocol", "does", "not", "include", "stratification", "after", "EGFR", "and", "ALK-", "mutation", "analysis", "and", "therefore", "does", "not", "exclude", "patients", "with", "positive", "mutations.The", "question", "whether", "checkpoint", "blockade", "should", "be", "performed", "before", "or", "after", "surgery", "has", "been", "addressed", "by", "Liu", "et", "al.", "in", "a", "preclinical", "breast-cancer", "model", "." ],
    "entities_indices" : [ [ 11, 12 ], [ 13, 14 ] ]
  }, {
    "sentence_tokens" : [ "Baseline", "inclusion", "criteria", "are", "non", "small", "cell", "histology", "in", "clinical", "stages", "IIA", "to", "IIIA.The", "decision", "for", "radical", "surgical", "therapy", "as", "an", "integral", "part", "of", "the", "therapy", "must", "be", "agreed", "on", "the", "oncological", "interdisciplinary", "tumor", "board", "." ],
    "entities_indices" : [ [ 33, 34 ] ]
  }, {
    "sentence_tokens" : [ "We", "hypothesize", "that", "the", "anti-neoplastic", "immune-stimulatory", "effect", "will", "be", "more", "effective", "in", "patients", "treated", "prior", "to", "tumor", "resection", "." ],
    "entities_indices" : [ [ 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "Antibodies", "blocking", "the", "ligation", "of", "PD-1", "and", "PD-L1", "have", "been", "investigated", "in", "recent", "clinical", "trials", "in", "NSCLC", "stage", "IV", "patients", "(", "KEYNOTE-trials", ")", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 7, 8 ] ]
  }, {
    "sentence_tokens" : [ "Nevertheless", ",", "TNM", "classification", "from", "the", "7th", "and", "the", "actual", "valid", "8th", "edition", "will", "both", "be", "provided", "[", "5", ",", "20", "]", "." ],
    "entities_indices" : [ [ 2, 3 ] ]
  }, {
    "sentence_tokens" : [ "Nevertheless", ",", "the", "NEOMUN-trial", "aims", "to", "include", "untreated", "patients", "with", "stage", "II/IIIA1", "-", "3", "NSCLC", "." ],
    "entities_indices" : [ [ 11, 12, 13, 14, 15 ] ]
  }, {
    "sentence_tokens" : [ ")", ",", "tumor", "resection", "with", "lobectomy", "or", "bilobectomy", "will", "be", "performed", "." ],
    "entities_indices" : [ [ 2, 3 ] ]
  }, {
    "sentence_tokens" : [ "A", "subset", "of", "patients", "meeting", "RECIST", "1.1", "criteria", "for", "disease", "progression", "(", "in", "size", "or", "number", "of", "lesions", ")", "showed", "delayed", "but", "durable", "responses", "to", "therapy", "by", "time", "." ],
    "entities_indices" : [ [ 9, 10, 11 ] ]
  }, {
    "sentence_tokens" : [ "In", "NSCLC", ",", "clinical", "data", "on", "neoadjuvant", "immunomodulatory", "treatment", "is", "scarce", "but", "few", "encouraging", "trials", "investigating", "anti-PD-1", "and", "PD-L1", "checkpoint", "inhibition", "prior", "to", "surgery", "for", "NSCLC", "patients", "are", "currently", "ongoing", "(", "e.g", "." ],
    "entities_indices" : [ [ 16, 17 ], [ 18, 19 ] ]
  }, {
    "sentence_tokens" : [ "Based", "upon", "preliminary", "promising", "results", "from", "the", "KEYNOTE-trials", ",", "the", "combination", "of", "Pembrolizumab", "and", "pemetrexed", "and", "carboplatin", "chemotherapy", "has", "been", "recently", "approved", "as", "first-line", "treatment", "for", "metastatic", "or", "advanced", "NSCLC", "regardless", "of", "the", "PD-L1", "expression", "[", "27", "]", "." ],
    "entities_indices" : [ [ 12, 13 ], [ 16, 17 ], [ 33, 34 ] ]
  }, {
    "sentence_tokens" : [ "In", "order", "to", "evaluate", "a", "correlation", "between", "the", "mutational-load", "and", "transcriptome", "of", "the", "tumor", "and", "the", "peripheral", "blood", ",", "whole", "exome", "sequencing", "of", "cell", "free", "plasma", "DNA", "will", "be", "performed.Data", "of", "the", "patients", "participating", "in", "the", "NEOMUN", "trial", "will", "be", "compared", "to", "patient", "data", "from", "an", "institutional", "biobank", "cohort", "matched", "to", "age", ",", "gender", ",", "stage", "of", "disease", "and", "tumor", "dependent", "parameters", "(", "histology", ",", "size", ",", "nodal", "status", ")", "." ],
    "entities_indices" : [ [ 13, 14 ], [ 59, 60 ] ]
  }, {
    "sentence_tokens" : [ "Start", "of", "patient", "enrollment", "is", "scheduled", "for", "June", "2018", "." ],
    "entities_indices" : [ [ 0, 1 ] ]
  }, {
    "sentence_tokens" : [ "After", "completion", "of", "the", "initially", "recommended", "tumor", "specific", "therapy", ",", "routine", "follow", "up", "will", "be", "performed", "every", "three", "months", "up", "to", "24", "months", "and", "includes", "thoracic", "and", "abdominal", "sectional", "imaging", "as", "well", "as", "lung", "function", "assessment", "." ],
    "entities_indices" : [ [ 6, 7 ] ]
  }, {
    "sentence_tokens" : [ "Immunotherapies", "targeting", "the", "PD1", "and", "PD-L1", "pathway", "have", "had", "a", "large", "impact", "on", "the", "treatment", "of", "advanced", "NSCLC", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 5, 6 ] ]
  }, {
    "sentence_tokens" : [ "Ligation", "of", "PD1", "and", "PD-L1", "suppresses", "activated", "T-cells", ",", "thus", "resulting", "in", "impaired", "anti-tumor", "immunity", "[", "10", ",", "11", "]", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 4, 5 ], [ 14, 15 ] ]
  }, {
    "sentence_tokens" : [ "Treatment", "of", "selected", "patients", "(", "PD-L1", "expression", "on", "at", "least", "50", "%", "of", "the", "tumor-cells", ",", "no", "EGF", "receptor", "mutation", "or", "ALK", "translocation", ")", "with", "a", "monoclonal", "humanized", "antibody", "against", "PD-1", "(", "Pembrolizumab", ",", "KEYTRUDA", "(c)", ")", "correlated", "with", "an", "increased", "progression-free", "survival", "(", "median", "10.3", "months", "vs.", "6.0", "months", ",", "p", "<", "0.001", ")", "and", "an", "overall", "survival", "of", "80.2", "%", "at", "6", "months", "compared", "to", "72.4", "%", "in", "patients", "receiving", "standard", "chemotherapy", "(", "p", "<", "0.005", ")", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 17, 18, 19 ], [ 21, 22 ], [ 30, 31 ], [ 32, 33 ], [ 34, 35 ] ]
  }, {
    "sentence_tokens" : [ "From", "a", "biological", "point", "of", "view", "dynamic", "induction", "of", "PD-L1", "expression", "and", "an", "intratumoral", "heterogeneity", "of", "PDL-1", "expression", "may", "result", "in", "a", "false", "negative", "PD-L1", "status", "and", "may", "not", "be", "accurately", "investigated", "by", "small", "sample", "biopsies", "." ],
    "entities_indices" : [ [ 9, 10 ], [ 16, 17 ], [ 24, 25 ] ]
  }, {
    "sentence_tokens" : [ "The", "authors", "reported", "about", "an", "increased", "tumor", "specific", "CD8+", "T-cell", "response", "in", "patients", "after", "neoadjuvant", "immunotherapy", "[", "33", "]", "." ],
    "entities_indices" : [ [ 6, 7 ], [ 8, 9 ] ]
  }, {
    "sentence_tokens" : [ "This", "observation", "limit", "will", "exclude", "individual", "Pembrolizumab", "related", "SAEs", "but", "covers", "most", "of", "the", "historical", "reference", "events", "and", "rates", "(", "e.g", "." ],
    "entities_indices" : [ [ 6, 7, 8, 9 ] ]
  }, {
    "sentence_tokens" : [ "This", "is", "supported", "by", "a", "comparative", "study", "investigating", "the", "PD-L1", "status", "in", "surgically", "resected", "specimens", "and", "matched", "biopsies", "of", "NSCLC", "patients", "." ],
    "entities_indices" : [ [ 9, 10 ] ]
  }, {
    "sentence_tokens" : [ "Less", "than", "two", "thirds", "of", "all", "patients", "with", "a", "newly", "diagnosed", "NSCLC", "have", "the", "chance", "of", "a", "curative", "treatment", "." ],
    "entities_indices" : [ [ 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "Pembrolizumab", "(", "KEYTRUDA", "(R)", ")", "will", "be", "administered", "in", "a", "neoadjuvant", "setting", "to", "patients", "with", "resectable", "NSCLC", "stage", "II/IIIA", "who", "are", "eligible", "for", "curative", "intent", "surgery", "." ],
    "entities_indices" : [ [ 0, 1 ] ]
  }, {
    "sentence_tokens" : [ "Of", "major", "interest", "is", "the", "analysis", "of", "possible", "therapy", "associated", "changes", "in", "different", "tumor", "regions", "(", "eg", "." ],
    "entities_indices" : [ [ 13, 14 ] ]
  }, {
    "sentence_tokens" : [ "Exploratory", "objective", "is", "to", "analyze", "potential", "predictive", "biomarkers", "and", "to", "evaluate", "the", "therapeutic", "efficacy", "of", "Pembrolizumab", "by", "extended", "immune", "cell", "and", "cytokine", "analysis", "of", "tumor", "tissue.The", "study", "protocol", "was", "approved", "by", "the", "local", "ethics", "committee", "and", "the", "federal", "authority", "." ],
    "entities_indices" : [ [ 15, 16 ], [ 24, 25 ] ]
  }, {
    "sentence_tokens" : [ "Their", "trial", "(", "NCT02259621", ")", "investigated", "safety", "and", "feasibility", "of", "patients", "with", "early", "stage", "I-IIIa", "NSCLC", "treated", "neoadjuvantly", "with", "2", "doses", "of", "nivolumab", "." ],
    "entities_indices" : [ [ 22, 23 ] ]
  }, {
    "sentence_tokens" : [ "To", "date", ",", "there", "is", "no", "neoadjuvant", "or", "adjuvant", "EGFR-", "or", "ALK-TKI", "therapy", "authorized", "in", "this", "patient", "cohort", "." ],
    "entities_indices" : [ [ 9, 10 ], [ 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "Investigational", "drug", "is", "Pembrolizumab", "." ],
    "entities_indices" : [ [ 3, 4 ] ]
  }, {
    "sentence_tokens" : [ "Depending", "on", "the", "individual", "tumor", "stage", "and", "postsurgical", "physical", "recovery", ",", "adjuvant", "chemotherapy", "will", "be", "recommended", "according", "to", "the", "current", "national", "and", "international", "guidelines", "." ],
    "entities_indices" : [ [ 4, 5 ] ]
  }, {
    "sentence_tokens" : [ "However", ",", "the", "efficacy", "of", "Pembrolizumab", "as", "a", "first-line", "treatment", "in", "advanced", "and/or", "metastatic", "NSCLC", "patients", "with", "PD-L1", "expression", "below", "50", "%", "is", "under", "debate", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 17, 18 ] ]
  }, {
    "sentence_tokens" : [ "pneumonia", ",", "pleural", "effusion", ",", "pneumonitis", ",", "dyspnea", ",", "pulmonary", "embolism", "]", ",", "reported", "pathological", "and", "radiological", "response", "rates", "to", "Pembrolizumab", "treatment", ")", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 2, 3, 4 ], [ 7, 8 ], [ 9, 10, 11 ] ]
  }, {
    "sentence_tokens" : [ "Several", "authors", "have", "also", "reported", "about", "rare", "concomitant", "expression", "of", "EGFR", ",", "ALK", "and/or", "PD-L1", "and", "thus", "they", "so", "far", "refuted", "their", "mutual", "exclusiveness", "[", "31", ",", "32", "]", "." ],
    "entities_indices" : [ [ 10, 11 ], [ 12, 13 ], [ 14, 15 ] ]
  }, {
    "sentence_tokens" : [ "Clinical", "or", "radiological", "findings", "suspicious", "for", "tumor", "recurrence", "will", "result", "in", "whole", "body", "restaging", "and", "further", "individual", "examination", "." ],
    "entities_indices" : [ [ 6, 7 ], [ 7, 8 ] ]
  }, {
    "sentence_tokens" : [ "Patients", "with", "NSCLC", "and", "nodal", "N1", "and/or", "N2", "disease", "suffer", "from", "an", "overall", "relapse", "rate", "of", "52", "%", "even", "when", "multimodality", "treatment", "including", "curative", "intent", "surgery", "with", "chemo-", "and/or", "radiotherapy", "is", "administered", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 4, 5 ] ]
  }, {
    "sentence_tokens" : [ "Concerning", "multimodality", "tumor", "therapy", ",", "only", "few", "trials", "until", "today", "have", "been", "performed", "investigating", "neoadjuvant", "treatment", "with", "anti", "PD-1", "immunotherapy", "prior", "to", "curative", "intent", "surgery", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 18, 19 ] ]
  }, {
    "sentence_tokens" : [ "Each", "patient", "will", "be", "followed", "up", "24", "months", "after", "completion", "of", "the", "entire", "tumor", "therapy", "(", "Fig.", "1", ")", "." ],
    "entities_indices" : [ [ 13, 14 ] ]
  }, {
    "sentence_tokens" : [ "These", "findings", "resulted", "in", "the", "recent", "approval", "of", "Pembrolizumab", "as", "first", "line-treatment", "for", "patients", "with", "a", "PD-L1", "expression", ">", "50", "%", "." ],
    "entities_indices" : [ [ 8, 9 ], [ 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "An", "adverse", "event", "can", "therefore", "be", "any", "unfavorable", "and", "unintended", "sign", "(", "including", "an", "abnormal", "laboratory", "finding", ",", "for", "example", ")", ",", "symptom", ",", "or", "disease", "temporally", "associated", "with", "the", "use", "of", "a", "medicinal", "(", "investigational", ")", "product", ",", "whether", "or", "not", "considered", "related", "to", "the", "medicinal", "(", "investigational", ")", "product.A", "serious", "adverse", "event", "(", "SAE", ")", "is", "defined", "as", "any", "untoward", "medical", "occurrence", "(", "adverse", "event", ")", "that", "at", "any", "dose", "results", "in", "death", ",", "is", "life", "threatening", ",", "requires", "new", "or", "prolonged", "in-patient", "hospitalization", ",", "results", "in", "persistent", "or", "significant", "disability", "and", "incapacity", ",", "is", "a", "congenital", "anomaly", "and", "birth", "defect", "or", ",", "any", "other", "significant", "medical", "condition.Progression", "of", "the", "NSCLC", "and", "symptoms", "caused", "by", "progression", "of", "the", "NSCLC", "need", "not", "to", "be", "reported", "as", "SAE", "in", "this", "protocol", ",", "unless", "progression", "or", "symptoms", "of", "progression", "are", "assessed", "as", "causally", "related", "to", "study", "medication", "." ],
    "entities_indices" : [ [ 74, 75 ], [ 101, 102, 103 ], [ 112, 113 ], [ 120, 121 ], [ 127, 128 ] ]
  }, {
    "sentence_tokens" : [ "Specific", "interactions", "between", "tumor", "and", "immune-cells", "will", "be", "examined", "by", "further", "research", "on", "neo-epitope-", "specific", "T-cell", "responses", "and", "T-cell-receptor", "-clonality", "analysis", "." ],
    "entities_indices" : [ [ 3, 4 ] ]
  }, {
    "sentence_tokens" : [ "Major", "pathologic", "tumor", "response", "(", "defined", "as", "less", "than", "10", "%", "viable", "tumor", "cells", "posttreatment", ")", "was", "observed", "in", "9", "of", "21", "(", "43", "%", ")", "resected", "tumors", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 27, 28 ] ]
  }, {
    "sentence_tokens" : [ "inflammatory", "infiltrates", "in", "and", "around", "the", "resected", "tumor", ",", "serum-", "and", "tumor", "tissue", "cytokine", "concentrations", ",", "multi-OMICS", "tissue", "analysis", ";", "see", "section", "\"", "Translational", "research", "\"", ")", "in", "order", "to", "generate", "a", "hypothesis", "on", "potential", "biomarkers", "predicting", "the", "efficacy", "of", "Pembrolizumab", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 11, 12 ], [ 40, 41 ] ]
  }, {
    "sentence_tokens" : [ "Primary", "endpoints", "are", "to", "evaluate", "the", "frequency", "and", "severity", "of", "adverse", "events", "including", "peri-", "and", "post-operative", "complications", "(", "grade", "2", "-", "4", "AEs", "according", "to", "NCI-CTCAE", "V4.03", ")", "in", "all", "participants", "." ],
    "entities_indices" : [ [ 22, 23 ], [ 25, 26, 27 ] ]
  }, {
    "sentence_tokens" : [ "Besides", "others", ",", "these", "molecules", "are", "expressed", "on", "the", "tumor", "cell", "surface", "(", "PD-L1", ")", "or", "the", "patients", "activated", "T-cells", "(", "PD-1", ")", "." ],
    "entities_indices" : [ [ 13, 14 ], [ 21, 22 ] ]
  }, {
    "sentence_tokens" : [ "A", "correlation", "between", "positive", "EGFR", "mutation", "and", "high", "PD-L1", "expression", "in", "a", "historical", "cohort", "analysis", "of", "surgically", "resected", "NSCLC", "has", "been", "shown", "by", "Azuma", "et", "al.", "[", "30", "]", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 8, 9 ], [ 18, 19 ] ]
  }, {
    "sentence_tokens" : [ "The", "research", "endeavor", "will", "be", "flanked", "by", "a", "translational", "research", "program", "to", "elucidate", "potential", "predictive", "biomarkers", "and", "to", "investigate", "the", "mode", "of", "action", "of", "anti", "PD-1", "treatment", "in", "NSCLC", "patients", "." ],
    "entities_indices" : [ [ 25, 26 ] ]
  }, {
    "sentence_tokens" : [ "The", "study", "is", "designed", "as", "a", "mono-center", ",", "open-label", ",", "single", "arm", ",", "prospective", ",", "phase", "II", "study", "." ],
    "entities_indices" : [ [ 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "body", "weight", ",", "height", ",", "thoracic", "anatomy", "and", "tumor", "location", ")", ",", "access", "into", "the", "chest", "cavity", "will", "be", "provided", "either", "by", "open", "surgery", "(", "anterolateral", "horizontal", "incision", "over", "the", "3rd", "to", "5th", "intercostal", "space", ")", "or", "endoscopic", "surgery", "(", "video", "assisted", "thoracoscopy", ";", "one", "to", "three", "individually", "placed", "small", "utility", "incisions", "triangulated", "over", "the", "lateral", "chest", "wall", ")", "." ],
    "entities_indices" : [ [ 0, 1, 2 ], [ 8, 9 ] ]
  }, {
    "sentence_tokens" : [ "Enlarged", "(", ">", "1", "cm", "in", "conventional", "chest", "CT", ")", "or", "PET", "positive", "mediastinal", "lymph", "nodes", "will", "be", "clarified", "by", "EBUS", "guided", "biopsy", "." ],
    "entities_indices" : [ [ 8, 9 ], [ 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "Assessing", "the", "induction", "of", "tumor", "specific", "immunity", "will", "help", "to", "more", "intensively", "explore", "potential", "immunotherapy", "associated", "changes", "in", "the", "tumor", "and", "its", "microenvironment", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 6, 7 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Nevertheless", ",", "survival", "of", "patients", "in", "stages", "IIA", "and", "IIB", "with", "nodal", "tumor", "involvement", "(", "N1", ")", "is", "estimated", "between", "55", "and", "35", "%", "at", "five", "years", "and", "is", "even", "worse", "(", "15", "to", "40", "%", ")", "for", "patients", "with", "locally", "resectable", "tumors", "but", "limited", "nodal", "N2-disease", "." ],
    "entities_indices" : [ [ 12, 13 ], [ 42, 43 ] ]
  }, {
    "sentence_tokens" : [ "This", "also", "accounts", "for", "EGFR", "or", "ALK", "positive", "tumors", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 6, 7 ], [ 8, 9 ] ]
  }, {
    "sentence_tokens" : [ "The", "whole", "study", "will", "be", "stopped", "in", "the", "event", "of", "any", "of", "the", "following", ":", "Medical", "or", "ethical", "reasons", "affecting", "the", "continued", "performance", "of", "the", "studyOccurrence", "of", "AEs", "unknown", "to", "date", "in", "respect", "of", "their", "nature", ",", "severity", ",", "and", "duration", "or", "the", "unexpected", "incidence", "of", "known", "AE", "with", "a", "negative", "impact", "on", "the", "risk", "and", "benefit", "assessmentmedically", "unacceptable", "risks", "for", "the", "treatment", "of", "the", "patientsAt", "the", "interim", "analysis", "(", "15", "patients", "included", ")", ":", "if", "the", "rate", "of", "unresectability", "is", "equal", "or", "greater", "20", "%", ";", "i.e.", "if", "3/15", "or", "more", "study", "subjects", "did", "not", "undergo", "surgery", "as", "planned", "according", "to", "the", "protocol", "(", "unresectable", "disease", "or", "excessive", "delay", "of", "surgery", ")", "." ],
    "entities_indices" : [ [ 27, 28 ], [ 47, 48 ] ]
  }, {
    "sentence_tokens" : [ "In", "a", "first", "interim", "analysis", ",", "Forde", "et", "al.", "recently", "published", "data", "on", "patients", "with", "NSCLC", "receiving", "neoadjuvant", "anti-PD-1", "therapy", "(", "Nivolumab", ")", "." ],
    "entities_indices" : [ [ 15, 16 ] ]
  }, {
    "sentence_tokens" : [ "Tumor", "core", "vs.", "marginal", "zone", ")", ",", "the", "mediastinal", "and", "hilar", "lymph-nodes", ",", "the", "healthy", "lung", "tissue", "and", "the", "peripheral", "blood", "." ],
    "entities_indices" : [ [ 0, 1 ] ]
  }, {
    "sentence_tokens" : [ "In", "all", "cases", "the", "biopsy", "specimens", "underestimated", "the", "PDL-1", "status", "observed", "on", "the", "whole", "tissue", "sample", "[", "28", "]", "." ],
    "entities_indices" : [ [ 8, 9 ] ]
  }, {
    "sentence_tokens" : [ "bladder", "cancer", ",", "melanoma", ",", "clinicaltrials.gov", ")", "." ],
    "entities_indices" : [ [ 3, 4 ] ]
  }, {
    "sentence_tokens" : [ "Importantly", ",", "this", "tumor", "response", "did", "not", "correlate", "with", "the", "pre-treatment", "PD-L1", "status", "assessed", "in", "tumor", "biopsies", "by", "immunohistochemistry.Moreover", ",", "the", "techniques", "used", "to", "quantitatively", "assess", "the", "PDL-1", "status", "in", "small", "pre-treatment", "biopsies", "are", "under", "critical", "debate", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 11, 12 ], [ 15, 16 ], [ 27, 28 ] ]
  }, {
    "sentence_tokens" : [ "Special", "interest", "has", "been", "raised", "by", "so", "called", "regulatory", "immune-inhibitory", "pathways", "including", "the", "programmed", "death-receptor", "1", "(", "PD-1", ")", "and", "its", "ligand", "(", "PD-L1", ")", "." ],
    "entities_indices" : [ [ 14, 15 ], [ 17, 18 ], [ 21, 22 ], [ 23, 24 ] ]
  }, {
    "sentence_tokens" : [ "Immunotherapy", "associated", "tumor", "response", "will", "be", "assessed", "byradiological", "change", "(", "Delta", "tumor", "size", "/", "lymph", "node", "size", ")", ",", "according", "to", "RECIST", "[", "13", "]", "and", "iRECIST", "*", "(", "[", "14", "]", ")", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 10, 11 ], [ 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "tumor", "markers", ",", "peripheral", "blood", "mononuclear", "cells", ",", "antibody", "profiles", "and", "cellular", "as", "well", "humoral", "immune", "related", "response", "parameters", "." ],
    "entities_indices" : [ [ 0, 1 ] ]
  }, {
    "sentence_tokens" : [ "Aim", "of", "the", "NEOMUN", "investigator", "initiated", "trial", "(", "EudraCT-Number", ":", "2017-000105-20", ";", "ClinicalTrials.gov", "Identifier", ":", "NCT03197467", ")", "is", "to", "assess", "feasibility", "and", "safety", "of", "pre-surgical", "anti", "PD-1", "treatment", "in", "order", "to", "improve", "long", "term", "survival", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 26, 27 ] ]
  }, {
    "sentence_tokens" : [ "Time-to-event", "measures", "(", "OS", ",", "DFS", ")", "will", "be", "analyzed", "by", "means", "of", "Kaplan-Meier", "curves", "." ],
    "entities_indices" : [ [ 3, 4 ] ]
  }, {
    "sentence_tokens" : [ "Primary", "Objectives", "are", "to", "assess", "the", "feasibility", "and", "safety", "of", "a", "neoadjuvant", "application", "of", "Pembrolizumab", "and", "to", "evaluate", "the", "effectivity", "of", "an", "anti-PD1-treatment", "on", "clinical", "and", "pathologic", "tumor", "response.Secondary", "Objective", "is", "to", "assess", "the", "impact", "of", "neoadjuvant", "Pembrolizumab", "application", "on", "patient", "disease", "free-", "and", "overall", "survival.Exploratory", "objective", "is", "the", "translational", "assessment", "of", "treated", "and", "untreated", "tumors", "(", "e.g", "." ],
    "entities_indices" : [ [ 14, 15 ], [ 27, 28 ], [ 37, 38 ], [ 55, 56 ] ]
  }, {
    "sentence_tokens" : [ "The", "NEOMUN", "trial", "will", "be", "one", "of", "the", "first", "clinical", "trials", "investigating", "a", "multimodal", "treatment", "strategy", "including", "neoadjuvant", "immunotherapy", "using", "Pembrolizumab", "as", "an", "investigational", "drug", "." ],
    "entities_indices" : [ [ 20, 21 ] ]
  }, {
    "sentence_tokens" : [ "Clinical", "staging", "will", "be", "proceeded", "in", "accordance", "to", "the", "actual", "TNM", "classification", "." ],
    "entities_indices" : [ [ 10, 11 ] ]
  }, {
    "sentence_tokens" : [ "An", "adverse", "event", "(", "AE", ")", "is", "defined", "in", "the", "International", "Conference", "on", "Harmonization", "(", "ICH", ")", "Guideline", "for", "Good", "Clinical", "Practice", "as", "\"", "any", "untoward", "medical", "occurrence", "in", "a", "patient", "or", "clinical", "investigation", "subject", "administered", "a", "pharmaceutical", "product", "and", "which", "does", "not", "necessarily", "have", "a", "causal", "relationship", "with", "this", "treatment", "\"", "(", "ICH", "E6", ":", "section", "1.2", ")", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 54, 55 ] ]
  }, {
    "sentence_tokens" : [ "Polarization", "of", "tumor", "associated", "macrophages", "(", "TAMs", ")", "in", "response", "to", "anti", "PD-1", "treatment", "will", "be", "investigated.Workup", "of", "pre-", "and", "posttreatment", "blood", "will", "focus", "on", "cytokine", "-/chemokine-profiles", "and", "antibody-profiles", "using", "multiplex", "assays", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 12, 13 ] ]
  }, {
    "sentence_tokens" : [ "A", "contrast", "enhanced", "thoracic", "computed", "tomography", "(", "CT", ")", "will", "initially", "be", "performed", "in", "all", "patients", "that", "are", "screened", "for", "the", "trial", "." ],
    "entities_indices" : [ [ 7, 8 ] ]
  } ],
  "emptySentences" : [ ]
}